Clinical trials
Diabetes Mellitus, Type 2 trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
311 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 5 |
| 2004 | 4 |
| 2005 | 7 |
| 2006 | 24 |
| 2007 | 12 |
| 2008 | 14 |
| 2009 | 19 |
| 2010 | 29 |
| 2011 | 13 |
| 2012 | 12 |
| 2013 | 17 |
| 2014 | 18 |
| 2015 | 9 |
| 2016 | 14 |
| 2017 | 17 |
| 2018 | 10 |
| 2019 | 9 |
| 2020 | 9 |
| 2021 | 9 |
| 2022 | 12 |
| 2023 | 10 |
| 2024 | 15 |
| 2025 | 3 |
| 2026 | 19 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 222 |
| Unknown status | 29 |
| Recruiting | 23 |
| Terminated | 16 |
| Active, not recruiting | 7 |
| Not yet recruiting | 6 |
| Withdrawn | 5 |
| Suspended | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 37 |
| Eli Lilly and Company | 34 |
| AstraZeneca | 24 |
| Hospital de Clinicas de Porto Alegre | 21 |
| Sanofi | 18 |
| Takeda | 12 |
| University of Sao Paulo | 12 |
| University of Sao Paulo General Hospital | 12 |
| University of Campinas, Brazil | 11 |
| Hoffmann-La Roche | 10 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 311 |
| Diabetes Mellitus | 88 |
| Obesity | 24 |
| Insulin Resistance | 19 |
| Glucose Metabolism Disorders | 16 |
| Renal Insufficiency, Chronic | 14 |
| Overweight | 12 |
| Dyslipidemias | 11 |
| Metabolic Diseases | 9 |
| Cardiovascular Diseases | 8 |
Trials
Showing 76 to 100 of 311. Each trial links to its page on Pharma Observatory.
211 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.